Samsung BioLogics lands $1.3 billion U.S. contract amid tariff uncertainty
1. $1.3 billion contract through 2029 makes this one of Samsung BioLogics’ largest agreements. 2. Expansion plans to nearly 1 ...
1. $1.3 billion contract through 2029 makes this one of Samsung BioLogics’ largest agreements. 2. Expansion plans to nearly 1 ...
1. First intranasal loop diuretic approved by the FDA for heart, kidney, and liver disease patients. 2. Clinical trials showed ...
Google’s AI matches dermatologists in melanoma diagnosis England’s health service is piloting an artificial intelligence tool called Deep Ensemble for ...
Key Points: 1. Over 250 branded drugs saw price increases in the U.S., including Paxlovid and cancer therapies. 2. Median ...
Key Points: 1. European pharma leaders push for higher drug prices to boost global competitiveness. 2. CEOs warn EU may ...
Key Points: 1. Lilly sues four telehealth firms for unauthorized compounding of Mounjaro and Zepbound. 2. GLP 1 drugs remain ...
Key Points: 1. FDA approves Dupixent as the first new CSU treatment in over a decade. 2. Phase 3 trial ...
1. Polypharmacy was associated with a greater risk of mortality and hospitalizations at one and five years. Evidence Rating Level: ...
1. Screening for drug abuse in adult populations by asking questions during patient appointments was found to have moderate net ...
1. The Tobacco, Alcohol, Prescription Medication, and other Substance use (TAPS) tool can screen and access for tobacco, alcohol, and ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.